International Journal of Community Medicine and Public Health 2025

1 papers

Top Research Directions

The 3 research directions with International Journal of Community Medicine and Public Health 2025 papers, ranked by paper count, next to 2024. Share is the fraction of the edition’s papers in the direction.

#Direction20252024Share 2025Share 20242024 rank
1Acute Infection Induced Metabolic Dysfunction10100.0%0.0%—
2Exclusionary Cohort Filtering for Confounder Isolation10100.0%0.0%—
3Tracking Dynamic Biomarker Trajectories Over Time10100.0%0.0%—

Download all directions as CSV

Institutions

Institutions credited by International Journal of Community Medicine and Public Health 2025 papers: a paper credits every institution named in its affiliations, once. 1 institutions share 1 credited papers.

#InstitutionPapersShare20242024 rank
101eadrh05 1100.0%0—

Download all institutions as CSV

About this data

Papers. International Journal of Community Medicine and Public Health 2025 lists 1 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2024 use shares, since the edition went from 1 to 1 papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 1 of 1 papers (100.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “International Journal of Community Medicine and Public Health 2025”, https://lacuna.tiptreesystems.com/venue/international-journal-of-community-medicine-and-public/2025.

Papers

Title
Study of new onset hyperglycemia and insulin resistance in COVID-19 patients